EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction

Ravi B Patel, Vivek Y Reddy, Jan Komtebedde, Stephan W Wegerich, Jadranka Sekaric, Vijay Swarup, Antony Walton, Gabriel Laurent, Stanley Chetcuti, Matthias Rademann, Martin Bergmann, Scott McKenzie und 19 weitere

JACC: Heart Failure · 2023-10 · 11 (10) · 1351-1362

DOI: 10.1016/j.jchf.2023.05.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Heart Failure, 2023-10. Verfasst von Ravi B Patel und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atrial fibrillation (AF) is a common comorbidity in patients with heart failure with preserved ejection fraction (HFpEF) and in heart failure with mildly reduced ejection fraction (HFmrEF). OBJECTIVES: This study sought to describe AF burden and its clinical impact among individuals with HFpEF and HFmrEF who participated in a randomized clinical trial of atrial shunt therapy (REDUCE LAP-HF II [A Study to Evaluate the Corvia Medical, Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients with Heart Failure]) and to evaluate the effect of atrial shunt therapy on AF burden. METHODS: Study investigators characterized AF burden among patients in the REDUCE LAP-HF II trial by using ambulatory cardiac patch monitoring at baseline (median patch wear time, 6 days) and over a 12-month follow-up (median patch wear time, 125 days). The investigators determined the association of baseline AF burden with long-term clinical events and examined the effect of atrial shunt therapy on AF burden over time. RESULTS: Among 367 patients with cardiac monitoring data at baseline and follow-up, 194 (53%) had a history of AF or atrial flutter (AFL), and median baseline AF burden was 0.012% (IQR: 0%-1.3%). After multivariable adjustment, baseline AF burden ≥0.012% was significantly associated with heart failure (HF) events (HR: 2.00; 95% CI: 1.17-3.44; P = 0.01) both with and without a history of AF or AFL (P for interaction = 0.68). Adjustment for left atrial reservoir strain attenuated the baseline AF burden-HF event association (HR: 1.71; 95% CI: 0.93-3.14; P = 0.08). Of the 367 patients, 141 (38%) had patch-detected AF during follow-up without a history of AF or AFL. Atrial shunt therapy did not change AF incidence or burden during follow-up. CONCLUSIONS: In HFpEF and HFmrEF, nearly 40% of patients have subclinical AF by 1 year. Baseline AF burden, even at low levels, is associated with HF events. Atrial shunt therapy does not affect AF incidence or burden. (A Study to Evaluate the Corvia Medical, Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients with Heart Failure [REDUCE LAP-HF II]; NCT03088033).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureHumansStroke VolumeHeart AtriaProsthesis ImplantationPrognosis

Stichwörter der Autor:innen

atrial fibrillationburdenclinical trialheart failureshunt

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Illino…
  • Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corvia Medical, Inc., Tewksbury, Massachusetts, USA.
  • physIQ Inc., Chicago, Illinois, USA.
  • Arizona Hearth Rhythm, Phoenix, Arizona, USA.
  • Heart Centre, Alfred Health, Melbourne, Australia.

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Patel, R. B., Reddy, V. Y., Komtebedde, J., Wegerich, S. W., Sekaric, J., Swarup, V., Walton, A., Laurent, G., Chetcuti, S., Rademann, M., Bergmann, M., McKenzie, S., Bugger, H., Bruno, R. R., Herrmann, H. C., Nair, A., Gupta, D. K., Lim, S., Kapadia, S., …, & Shah, S. J. (2023). Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure, 11(10), 1351-1362. https://doi.org/10.1016/j.jchf.2023.05.024

Vancouver

Patel RB, Reddy VY, Komtebedde J, Wegerich SW, Sekaric J, Swarup V, et al. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2023;11(10):1351-1362. doi:10.1016/j.jchf.2023.05.024

BibTeX
@article{Patel2023,
  author = {Patel, Ravi B and Reddy, Vivek Y and Komtebedde, Jan and Wegerich, Stephan W and Sekaric, Jadranka and Swarup, Vijay and Walton, Antony and Laurent, Gabriel and Chetcuti, Stanley and Rademann, Matthias and Bergmann, Martin and McKenzie, Scott and Bugger, Heiko and Bruno, Raphael Romano and Herrmann, Howard C and Nair, Ajith and Gupta, Deepak K and Lim, Scott and Kapadia, Samir and Gordon, Robert and Vanderheyden, Marc and Noel, Thomas and Bailey, Steven and Gertz, Zachary M and Trochu, Jean-Noël and Cutlip, Donald E and Leon, Martin B and Solomon, Scott D and van Veldhuisen, Dirk J and Auricchio, Angelo and Shah, Sanjiv J},
  title = {Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction},
  journal = {JACC: Heart Failure},
  year = {2023},
  volume = {11},
  number = {10},
  pages = {1351--1362},
  doi = {10.1016/j.jchf.2023.05.024}
}
Kostenlos starten →